{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:49:32Z","timestamp":1780710572270,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81872067"],"award-info":[{"award-number":["81872067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Doctoral Research Initiation Foundation of Liaoning Province","award":["201601121"],"award-info":[{"award-number":["201601121"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.biopha.2019.109771","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T06:00:32Z","timestamp":1577167232000},"page":"109771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR\/PI3K signaling pathway in lung adenocarcinoma"],"prefix":"10.1016","volume":"123","author":[{"given":"Yuqiang","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6161-205X","authenticated-orcid":false,"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2019.109771_bib0005","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2019.109771_bib0010","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.athoracsur.2018.06.058","article-title":"Predictors of pathologic tumor invasion and prognosis for ground glass opacity featured lung adenocarcinoma","volume":"106","author":"Ye","year":"2018","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.biopha.2019.109771_bib0015","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.5114\/aoms.2019.86707","article-title":"Long non-coding RNA FOXF1 adjacent non-coding developmental regulatory RNA inhibits growth and chemotherapy resistance in non-small cell lung cancer","volume":"15","author":"Xu","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.biopha.2019.109771_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-981-13-1426-1_8","article-title":"Functional analysis of circular RNAs","volume":"1087","author":"Shanmugapriya","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2019.109771_bib0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","article-title":"Circular RNA and its mechanisms in disease from the bench to the clinic","volume":"187","author":"Han","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2019.109771_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fonc.2018.00179","article-title":"Circular RNAs in cancer - lessons learned from microRNAs","volume":"8","author":"Dragomir","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2019.109771_bib0035","article-title":"The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function","author":"Zang","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2019.109771_bib0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/onc.2017.361","article-title":"Circular RNAs in cancer: opportunities and challenges in the field","volume":"37","author":"Kristensen","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2019.109771_bib0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.omtn.2019.02.005","article-title":"Circular RNAs in cancer","volume":"16","author":"Bach","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2019.109771_bib0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-018-0643-z","article-title":"Function and clinical significance of circRNAs in solid tumors","volume":"11","author":"Geng","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2019.109771_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-018-0569-5","article-title":"Circular RNAs: a new frontier for cancer diagnosis and therapy","volume":"11","author":"Zhang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2019.109771_bib0060","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.7150\/jca.24619","article-title":"Circular RNA circ_HIPK3 is down-regulated and suppresses cell proliferation, migration and invasion in osteosarcoma","volume":"9","author":"Xiao-Long","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2019.109771_bib0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12957-018-1515-2","article-title":"Progress in research on the role of circular RNAs in lung cancer","volume":"16","author":"Chen","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2019.109771_bib0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.prp.2017.02.011","article-title":"Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value","volume":"213","author":"Yao","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.biopha.2019.109771_bib0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jcb.26201","article-title":"Overexpression of circular RNA ciRS-7 abrogates the tumor suppressive effect of miR-7 on gastric cancer via PTEN\/PI3K\/AKT signaling pathway","volume":"119","author":"Pan","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2019.109771_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15384047.2018.1507254","article-title":"Circular RNA ciRS-7 triggers the migration and invasion of esophageal squamous cell carcinoma via miR-7\/KLF4 and NF-\u03baB signals","volume":"20","author":"Huang","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2019.109771_bib0085","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41419-018-0852-y","article-title":"CiRS-7 promotes growth and metastasis of esophageal squamous cell carcinoma via regulation of miR-7\/HOXB13","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2019.109771_bib0090","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-16-2541","article-title":"Circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal Cancer","volume":"23","author":"Weng","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2019.109771_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00432-016-2256-7","article-title":"The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma","volume":"143","author":"Xu","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biopha.2019.109771_bib0100","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.2147\/OTT.S158316","article-title":"Overexpressed CDR1as functions as an oncogene to promote the tumor progression via miR-7 in non-small-cell lung cancer","volume":"11","author":"Zhang","year":"2018","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.biopha.2019.109771_bib0105","first-page":"8712","article-title":"Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer","volume":"22","author":"Yan","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2019.109771_bib0110","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1111\/jcmm.13587","article-title":"CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-\u03baB signalling","volume":"22","author":"Su","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2019.109771_bib0115","first-page":"5285","article-title":"Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR\/PI3K signaling pathway","volume":"23","author":"Huang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2019.109771_bib0120","doi-asserted-by":"crossref","first-page":"39177","DOI":"10.18632\/oncotarget.16640","article-title":"The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2019.109771_bib0125","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ymthe.2019.05.011","article-title":"circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p\/FOXO3a axis in breast cancer","volume":"27","author":"Sang","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2019.109771_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-019-0969-3","article-title":"Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression","volume":"18","author":"Huang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2019.109771_bib0135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fonc.2019.00508","article-title":"Hsa_circ_0001946 inhibits lung cancer progression and mediates cisplatin sensitivity in non-small cell lung cancer via the nucleotide excision repair signaling pathway","volume":"9","author":"Huang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2019.109771_bib0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jtho.2015.09.014","article-title":"Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study)","volume":"11","author":"Kreuter","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.biopha.2019.109771_bib0145","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/cas.13704","article-title":"Resistin facilitates metastasis of lung adenocarcinoma through the TLR4\/Src\/EGFR\/PI3K\/NF-\u03baB pathway","volume":"109","author":"Gong","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2019.109771_bib0150","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.biopha.2017.07.120","article-title":"lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR\/PI3K\/AKT pathway","volume":"94","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109771_bib0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12935-019-0910-2","article-title":"p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR\/PI3K\/AKT signaling","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2019.109771_bib0160","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.bbrc.2018.06.158","article-title":"Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation","volume":"503","author":"Zhan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2019.109771_bib0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-018-0827-8","article-title":"Circular RNAs function as ceRNAs to regulate and control human cancer progression","volume":"17","author":"Zhong","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2019.109771_bib0170","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fonc.2019.00398","article-title":"CircPCMTD1 acts as the sponge of miR-224-5p to promote glioma progression","volume":"9","author":"Zheng","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2019.109771_bib0175","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.biopha.2018.12.120","article-title":"CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p\/SIRT1 axis and activating Wnt\/\u03b2-catenin signaling pathway","volume":"111","author":"Yao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109771_bib0180","first-page":"201","article-title":"MicroRNA-7 enhances cytotoxicity induced by gefitinib in non-small cell lung cancer via inhibiting the EGFR and IGF1R signalling pathways","volume":"19","author":"Zhao","year":"2015","journal-title":"Contemp. Oncol. (Pozn)"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219353934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219353934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:49:05Z","timestamp":1760096945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219353934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"alternative-id":["S0753332219353934"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109771","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR\/PI3K signaling pathway in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109771"}}